APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cancer Drug based on CAR-T

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cancer Drug based on CAR-T Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17397424032 January 2026177 pages

Choose your research edition.

Industry ResearchCancer Drug based on CAR-T Industry Research Report 2026100 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Drug based on CAR-T Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Cancer Drug based on CAR-T Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Drug based on CAR-T Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Drug based on CAR-T Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Cancer Drug based on CAR-T market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Cancer Drug based on CAR-T is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cancer Drug based on CAR-T is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cancer Drug based on CAR-T is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cancer Drug based on CAR-T is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cancer Drug based on CAR-T include Bristol-Myers Squibb, Fosun Kite Biotechnology, Gilead Sciences and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Cancer Drug based on CAR-T market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cancer Drug based on CAR-T and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cancer Drug based on CAR-T revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Cancer Drug based on CAR-T market size, projected growth trends, production technologies, key applications, and end-use industries.

Cancer Drug based on CAR-T Segment by Company

Bristol-Myers Squibb

Fosun Kite Biotechnology

Gilead Sciences

Novartis

Cancer Drug based on CAR-T Segment by Type

Allogeneic

Autologous

Cancer Drug based on CAR-T Segment by Application

Hospital

Pharmacy

Other

Cancer Drug based on CAR-T Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Drug based on CAR-T market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Drug based on CAR-T and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Drug based on CAR-T.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Cancer Drug based on CAR-T in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cancer Drug based on CAR-T industry.

Chapter 3: Detailed analysis of Cancer Drug based on CAR-T companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Drug based on CAR-Trevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cancer Drug based on CAR-T Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Allogeneic Table 3. Key Players of Autologous Table 4. Global Cancer Drug based on CAR-T Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Pharmacy Table 7. Key Players of Other Table 8. Global Cancer Drug based on CAR-T Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Cancer Drug based on CAR-T Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Cancer Drug based on CAR-T Market Share by Region (2021-2026) Table 11. Global Cancer Drug based on CAR-T Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Cancer Drug based on CAR-T Market Share by Region (2027-2032) Table 13. Cancer Drug based on CAR-T Industry Trends Table 14. Cancer Drug based on CAR-T Industry Drivers Table 15. Cancer Drug based on CAR-T Industry Opportunities and Challenges Table 16. Cancer Drug based on CAR-T Industry Restraints Table 17. Global Cancer Drug based on CAR-T Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Cancer Drug based on CAR-T Revenue Market Share by Company (2021-2026) Table 19. Global Cancer Drug based on CAR-T Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Cancer Drug based on CAR-T Key Company Head Office and Area Served Table 21. Global Cancer Drug based on CAR-T Company, Product Type & Application Table 22. Global Cancer Drug based on CAR-T Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Cancer Drug based on CAR-T by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Cancer Drug based on CAR-T Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cancer Drug based on CAR-T Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Cancer Drug based on CAR-T Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Cancer Drug based on CAR-T Revenue Market Share by Type (2021-2026) Table 29. Global Cancer Drug based on CAR-T Revenue Market Share by Type (2027-2032) Table 30. Global Cancer Drug based on CAR-T Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cancer Drug based on CAR-T Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Cancer Drug based on CAR-T Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Cancer Drug based on CAR-T Revenue Market Share by Application (2021-2026) Table 34. Global Cancer Drug based on CAR-T Revenue Market Share by Application (2027-2032) Table 35. Bristol-Myers Squibb Company Information Table 36. Bristol-Myers Squibb Business Overview Table 37. Bristol-Myers Squibb Cancer Drug based on CAR-T Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Bristol-Myers Squibb Cancer Drug based on CAR-T Product Portfolio Table 39. Bristol-Myers Squibb Recent Development Table 40. Fosun Kite Biotechnology Company Information Table 41. Fosun Kite Biotechnology Business Overview Table 42. Fosun Kite Biotechnology Cancer Drug based on CAR-T Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Fosun Kite Biotechnology Cancer Drug based on CAR-T Product Portfolio Table 44. Fosun Kite Biotechnology Recent Development Table 45. Gilead Sciences Company Information Table 46. Gilead Sciences Business Overview Table 47. Gilead Sciences Cancer Drug based on CAR-T Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Gilead Sciences Cancer Drug based on CAR-T Product Portfolio Table 49. Gilead Sciences Recent Development Table 50. Novartis Company Information Table 51. Novartis Business Overview Table 52. Novartis Cancer Drug based on CAR-T Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Novartis Cancer Drug based on CAR-T Product Portfolio Table 54. Novartis Recent Development Table 55. North America Cancer Drug based on CAR-T Market Size by Type (2021-2026) & (US$ Million) Table 56. North America Cancer Drug based on CAR-T Market Size by Type (2027-2032) & (US$ Million) Table 57. North America Cancer Drug based on CAR-T Market Size by Application (2021-2026) & (US$ Million) Table 58. North America Cancer Drug based on CAR-T Market Size by Application (2027-2032) & (US$ Million) Table 59. North America Cancer Drug based on CAR-T Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 60. North America Cancer Drug based on CAR-T Market Size by Country (2021-2026) Table 61. North America Cancer Drug based on CAR-T Market Size by Country (2027-2032) Table 62. Europe Cancer Drug based on CAR-T Market Size by Type (2021-2026) & (US$ Million) Table 63. Europe Cancer Drug based on CAR-T Market Size by Type (2027-2032) & (US$ Million) Table 64. Europe Cancer Drug based on CAR-T Market Size by Application (2021-2026) & (US$ Million) Table 65. Europe Cancer Drug based on CAR-T Market Size by Application (2027-2032) & (US$ Million) Table 66. Europe Cancer Drug based on CAR-T Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 67. Europe Cancer Drug based on CAR-T Market Size by Country (2021-2026) Table 68. Europe Cancer Drug based on CAR-T Market Size by Country (2027-2032) Table 69. China Cancer Drug based on CAR-T Market Size by Type (2021-2026) & (US$ Million) Table 70. China Cancer Drug based on CAR-T Market Size by Type (2027-2032) & (US$ Million) Table 71. China Cancer Drug based on CAR-T Market Size by Application (2021-2026) & (US$ Million) Table 72. China Cancer Drug based on CAR-T Market Size by Application (2027-2032) & (US$ Million) Table 73. Asia Cancer Drug based on CAR-T Market Size by Type (2021-2026) & (US$ Million) Table 74. Asia Cancer Drug based on CAR-T Market Size by Type (2027-2032) & (US$ Million) Table 75. Asia Cancer Drug based on CAR-T Market Size by Application (2021-2026) & (US$ Million) Table 76. Asia Cancer Drug based on CAR-T Market Size by Application (2027-2032) & (US$ Million) Table 77. Asia Cancer Drug based on CAR-T Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 78. Asia Cancer Drug based on CAR-T Market Size by Country (2021-2026) Table 79. Asia Cancer Drug based on CAR-T Market Size by Country (2027-2032) Table 80. South America, Middle East & Africa Cancer Drug based on CAR-T Market Size by Type (2021-2026) & (US$ Million) Table 81. South America, Middle East & Africa Cancer Drug based on CAR-T Market Size by Type (2027-2032) & (US$ Million) Table 82. South America, Middle East & Africa Cancer Drug based on CAR-T Market Size by Application (2021-2026) & (US$ Million) Table 83. South America, Middle East & Africa Cancer Drug based on CAR-T Market Size by Application (2027-2032) & (US$ Million) Table 84. South America, Middle East & Africa Cancer Drug based on CAR-T Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. South America, Middle East & Africa Cancer Drug based on CAR-T Market Size by Country (2021-2026) Table 86. South America, Middle East & Africa Cancer Drug based on CAR-T Market Size by Country (2027-2032) Table 87. Research Programs/Design for This Report Table 88. Authors List of This Report Table 89. Secondary Sources Table 90. Primary Sources List of Figures Figure 1. Cancer Drug based on CAR-T Product Image Figure 2. Global Cancer Drug based on CAR-T Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Cancer Drug based on CAR-T Market Share by Type: 2025 VS 2032 Figure 4. Allogeneic Image Figure 5. Autologous Image Figure 6. Global Cancer Drug based on CAR-T Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Cancer Drug based on CAR-T Market Share by Application: 2025 VS 2032 Figure 8. Hospital Image Figure 9. Pharmacy Image Figure 10. Other Image Figure 11. Global Cancer Drug based on CAR-T Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 13. Global Cancer Drug based on CAR-T Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Cancer Drug based on CAR-T Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Cancer Drug based on CAR-T Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Cancer Drug based on CAR-T Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Cancer Drug based on CAR-T Revenue Market Share by Type (2021-2032) Figure 20. Global Cancer Drug based on CAR-T Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cancer Drug based on CAR-T Revenue Market Share by Application (2021-2032) Figure 22. North America Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 23. North America Cancer Drug based on CAR-T Market Share by Type (2021-2032) Figure 24. North America Cancer Drug based on CAR-T Market Share by Application (2021-2032) Figure 25. North America Cancer Drug based on CAR-T Market Share by Country (2021-2032) Figure 26. United States Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 27. Canada Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 29. Europe Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 30. Europe Cancer Drug based on CAR-T Market Share by Type (2021-2032) Figure 31. Europe Cancer Drug based on CAR-T Market Share by Application (2021-2032) Figure 32. Europe Cancer Drug based on CAR-T Market Share by Country (2021-2032) Figure 33. Germany Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 34. France Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 36. Italy Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 37. Russia Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 39. China Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 40. China Cancer Drug based on CAR-T Market Share by Type (2021-2032) Figure 41. China Cancer Drug based on CAR-T Market Share by Application (2021-2032) Figure 42. Asia Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 43. Asia Cancer Drug based on CAR-T Market Share by Type (2021-2032) Figure 44. Asia Cancer Drug based on CAR-T Market Share by Application (2021-2032) Figure 45. Asia Cancer Drug based on CAR-T Market Share by Country (2021-2032) Figure 46. Japan Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 50. India Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 51. Australia Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Cancer Drug based on CAR-T Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Cancer Drug based on CAR-T Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Cancer Drug based on CAR-T Market Share by Country (2021-2032) Figure 56. Brazil Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 61. UAE Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 63. Chile Cancer Drug based on CAR-T Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Allogeneic
  • Autologous
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Bristol-Myers Squibb
  • Fosun Kite Biotechnology
  • Gilead Sciences
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Cancer Drug based on CAR-T Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Allogeneic
  5. 1.2.3 Autologous
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Cancer Drug based on CAR-T Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Pharmacy
  10. 1.3.4 Other
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Cancer Drug based on CAR-T Growth Trends by Region
  13. 1.5.1 Global Cancer Drug based on CAR-T Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Cancer Drug based on CAR-T Market Size by Region (2021-2026)
  15. 1.5.3 Cancer Drug based on CAR-T Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Cancer Drug based on CAR-T Market Dynamics
  1. 2.1 Cancer Drug based on CAR-T Industry Trends
  2. 2.2 Cancer Drug based on CAR-T Industry Drivers
  3. 2.3 Cancer Drug based on CAR-T Industry Opportunities and Challenges
  4. 2.4 Cancer Drug based on CAR-T Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Cancer Drug based on CAR-T Revenue by Company (2021-2026)
  2. 3.2 Global Cancer Drug based on CAR-T Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Cancer Drug based on CAR-T Key Company Head office and Area Served
  4. 3.4 Global Cancer Drug based on CAR-T Company, Product Type & Application
  5. 3.5 Global Cancer Drug based on CAR-T Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Cancer Drug based on CAR-T Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Cancer Drug based on CAR-T Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Cancer Drug based on CAR-T Tier 1, Tier 2, and Tier 3
4 Cancer Drug based on CAR-T Market by Type
  1. 4.1 Global Cancer Drug based on CAR-T Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Cancer Drug based on CAR-T Market Size by Type (2021-2032)
  3. 4.3 Global Cancer Drug based on CAR-T Market Size Share by Type (2021-2032)
5 Cancer Drug based on CAR-T Market by Application
  1. 5.1 Global Cancer Drug based on CAR-T Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Cancer Drug based on CAR-T Market Size by Application (2021-2032)
  3. 5.3 Global Cancer Drug based on CAR-T Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Bristol-Myers Squibb
  2. 6.1.1 Bristol-Myers Squibb Company Information
  3. 6.1.2 Bristol-Myers Squibb Business Overview
  4. 6.1.3 Bristol-Myers Squibb Cancer Drug based on CAR-T Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Bristol-Myers Squibb Cancer Drug based on CAR-T Product Portfolio
  6. 6.1.5 Bristol-Myers Squibb Recent Developments
  7. 6.2 Fosun Kite Biotechnology
  8. 6.2.1 Fosun Kite Biotechnology Company Information
  9. 6.2.2 Fosun Kite Biotechnology Business Overview
  10. 6.2.3 Fosun Kite Biotechnology Cancer Drug based on CAR-T Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Fosun Kite Biotechnology Cancer Drug based on CAR-T Product Portfolio
  12. 6.2.5 Fosun Kite Biotechnology Recent Developments
  13. 6.3 Gilead Sciences
  14. 6.3.1 Gilead Sciences Company Information
  15. 6.3.2 Gilead Sciences Business Overview
  16. 6.3.3 Gilead Sciences Cancer Drug based on CAR-T Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Gilead Sciences Cancer Drug based on CAR-T Product Portfolio
  18. 6.3.5 Gilead Sciences Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Cancer Drug based on CAR-T Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Novartis Cancer Drug based on CAR-T Product Portfolio
  24. 6.4.5 Novartis Recent Developments
7 North America
  1. 7.1 North America Cancer Drug based on CAR-T Market Size (2021-2032)
  2. 7.2 North America Cancer Drug based on CAR-T Market Size by Type
  3. 7.2.1 North America Cancer Drug based on CAR-T Market Size by Type (2021-2026)
  4. 7.2.2 North America Cancer Drug based on CAR-T Market Size by Type (2027-2032)
  5. 7.2.3 North America Cancer Drug based on CAR-T Market Share by Type (2021-2032)
  6. 7.3 North America Cancer Drug based on CAR-T Market Size by Application
  7. 7.3.1 North America Cancer Drug based on CAR-T Market Size by Application (2021-2026)
  8. 7.3.2 North America Cancer Drug based on CAR-T Market Size by Application (2027-2032)
  9. 7.3.3 North America Cancer Drug based on CAR-T Market Share by Application (2021-2032)
  10. 7.4 North America Cancer Drug based on CAR-T Market Size by Country
  11. 7.4.1 North America Cancer Drug based on CAR-T Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Cancer Drug based on CAR-T Market Size by Country (2021-2026)
  13. 7.4.3 North America Cancer Drug based on CAR-T Market Size by Country (2027-2032)
  14. 7.4.4 North America Cancer Drug based on CAR-T Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Cancer Drug based on CAR-T Market Size (2021-2032)
  2. 8.2 Europe Cancer Drug based on CAR-T Market Size by Type
  3. 8.2.1 Europe Cancer Drug based on CAR-T Market Size by Type (2021-2026)
  4. 8.2.2 Europe Cancer Drug based on CAR-T Market Size by Type (2027-2032)
  5. 8.2.3 Europe Cancer Drug based on CAR-T Market Share by Type (2021-2032)
  6. 8.3 Europe Cancer Drug based on CAR-T Market Size by Application
  7. 8.3.1 Europe Cancer Drug based on CAR-T Market Size by Application (2021-2026)
  8. 8.3.2 Europe Cancer Drug based on CAR-T Market Size by Application (2027-2032)
  9. 8.3.3 Europe Cancer Drug based on CAR-T Market Share by Application (2021-2032)
  10. 8.4 Europe Cancer Drug based on CAR-T Market Size by Country
  11. 8.4.1 Europe Cancer Drug based on CAR-T Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Cancer Drug based on CAR-T Market Size by Country (2021-2026)
  13. 8.4.3 Europe Cancer Drug based on CAR-T Market Size by Country (2027-2032)
  14. 8.4.4 Europe Cancer Drug based on CAR-T Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Cancer Drug based on CAR-T Market Size (2021-2032)
  2. 9.2 China Cancer Drug based on CAR-T Market Size by Type
  3. 9.2.1 China Cancer Drug based on CAR-T Market Size by Type (2021-2026)
  4. 9.2.2 China Cancer Drug based on CAR-T Market Size by Type (2027-2032)
  5. 9.2.3 China Cancer Drug based on CAR-T Market Share by Type (2021-2032)
  6. 9.3 China Cancer Drug based on CAR-T Market Size by Application
  7. 9.3.1 China Cancer Drug based on CAR-T Market Size by Application (2021-2026)
  8. 9.3.2 China Cancer Drug based on CAR-T Market Size by Application (2027-2032)
  9. 9.3.3 China Cancer Drug based on CAR-T Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Cancer Drug based on CAR-T Market Size (2021-2032)
  2. 10.2 Asia Cancer Drug based on CAR-T Market Size by Type
  3. 10.2.1 Asia Cancer Drug based on CAR-T Market Size by Type (2021-2026)
  4. 10.2.2 Asia Cancer Drug based on CAR-T Market Size by Type (2027-2032)
  5. 10.2.3 Asia Cancer Drug based on CAR-T Market Share by Type (2021-2032)
  6. 10.3 Asia Cancer Drug based on CAR-T Market Size by Application
  7. 10.3.1 Asia Cancer Drug based on CAR-T Market Size by Application (2021-2026)
  8. 10.3.2 Asia Cancer Drug based on CAR-T Market Size by Application (2027-2032)
  9. 10.3.3 Asia Cancer Drug based on CAR-T Market Share by Application (2021-2032)
  10. 10.4 Asia Cancer Drug based on CAR-T Market Size by Country
  11. 10.4.1 Asia Cancer Drug based on CAR-T Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Cancer Drug based on CAR-T Market Size by Country (2021-2026)
  13. 10.4.3 Asia Cancer Drug based on CAR-T Market Size by Country (2027-2032)
  14. 10.4.4 Asia Cancer Drug based on CAR-T Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Cancer Drug based on CAR-T Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Cancer Drug based on CAR-T Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Cancer Drug based on CAR-T Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Cancer Drug based on CAR-T Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Cancer Drug based on CAR-T Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Cancer Drug based on CAR-T Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Cancer Drug based on CAR-T Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Cancer Drug based on CAR-T Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Cancer Drug based on CAR-T Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Cancer Drug based on CAR-T Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Cancer Drug based on CAR-T Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Cancer Drug based on CAR-T Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Cancer Drug based on CAR-T Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Cancer Drug based on CAR-T Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst